Application of anti-TSLP antibody in preparation of drugs for treating chronic pruritus

A chronic and antibody technology, applied in the direction of antibodies, drug combinations, skin diseases, etc., can solve the problems that have not yet been reported in the application of chronic pruritus

Inactive Publication Date: 2017-07-14
ZHEJIANG CHINESE MEDICAL UNIVERSITY
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Although the anti-TSLP antibody has a certain therapeutic effect on the above diseases, so far, there has not been any relevant application report on the use of this antibody in the treatment of chronic pruritus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of anti-TSLP antibody in preparation of drugs for treating chronic pruritus
  • Application of anti-TSLP antibody in preparation of drugs for treating chronic pruritus
  • Application of anti-TSLP antibody in preparation of drugs for treating chronic pruritus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0023] 1. Experimental animals: In this experiment, SPF grade C57BL / 6 male mice (purchased from Jackson Laboratory in the United States), 6-8 weeks old, were provided with water and food arbitrarily, and 5 mice / cage were raised, including 10 mice in the solvent group. 10 rats in the urushiol group; 30 rats in the Iso IgG group, and 30 rats in the TSLP neutralizing antibody group.

[0024] 2. Preparation of experimental reagents:

[0025] ① Preparation of allergens:

[0026] 2.0% urushiol preparation: 2 parts by weight of urushiol (Phytolab, product number: 81080, Vestenbergsgreuth, Germany) was dissolved in 100 parts by weight of a mixed solvent of acetone and olive oil with a volume ratio of 1:4, and mixed.

[0027] Preparation of 0.5% urushiol: take 0.5 parts by weight of urushiol, dissolve in 100 parts by weight of acetone, and mix well.

[0028] ②Preparation of anti-TSLP antibody and isotype control IgG: anti-TSLP antibody (R&D Company, product number: MAB555) and isotyp...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of pruritus resistance, and specifically relates to an application of an anti-TSLP antibody in the preparation of drugs for treating chronic pruritus. The experiment results show that the provided anti-TSLP antibody can prominently relieve the symptoms of chronic pruritus caused by allergic contact dermatitis of mice, and moreover, under an effective treatment dosage, the coordinating ability of movement of mice is not influenced by the anti-TSLP antibody. The anti-TSLP antibody can be taken as the effective component of drugs, can be used to prepare anti-pruritus drugs, can be used to treat chronic pruritus in clinic, especially chronic pruritus caused by allergic contact dermatitis, and does not have a prominent side effect on the coordinating ability of movement.

Description

technical field [0001] The invention relates to the field of medicines for treating chronic pruritus, in particular to the application of anti-TSLP antibodies in the preparation of medicines for preventing and treating chronic pruritus. Background technique [0002] Pruritus is an unpleasant skin sensation that makes people want to scratch, and is a common clinical symptom of allergic contact dermatitis (hereinafter referred to as ACD). ACD is a very common skin disease in daily life, and it is also an occupational skin disease with a high incidence rate. Worldwide, the annual incidence of ACD is as high as 15‐20%. The main clinical symptoms of ACD include skin redness, rash, peeling, blisters, and itching. Patients often feel abnormal itching at the inflammatory site, causing repeated scratching of the affected area, which seriously affects the patient's emotional and mental state. Excessive scratching often further induces skin inflammation and stimulates skin nerve end...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/395A61P17/04
CPCA61K2039/505C07K16/244
Inventor 刘伯一台燕
Owner ZHEJIANG CHINESE MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products